We are live on ! Find out more
PGEBT

Pactiv General Employee Benefit Trust Portfolio holdings

AUM $8.68M
1-Year Est. Return 0.77%
This Fund
S&P 500
This Quarter Est. Return
-6.03%
1 Year Est. Return
+0.77%
3 Year Est. Return
+15.73%
5 Year Est. Return
+60.86%
10 Year Est. Return
AUM
$332M
AUM Growth
+$79.8M
Cap. Flow
+$112M
Cap. Flow %
33.81%
Top 10 Hldgs %
100%
Holding
3
New
2
Increased
Reduced
1
Closed

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$146M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCSH icon
1
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$233M 70.4%
+3,061,422
New +$235M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$75.9M 22.9%
201,312
-356,209
-64% -$146M
LQD icon
3
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$22.2M 6.7%
+201,940
New +$22.8M

Similar funds

Pactiv General Employee Benefit Trust's Q2 2022 Portfolio in Review

As of Q2 2022, Pactiv General Employee Benefit Trust held 3 positions worth $332M, up 32% from $252M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pactiv General Employee Benefit Trust deployed $112M of net new capital in Q2 2022, opening 2 new positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 3,061,422 shares worth $233M.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $146M trimmed.

  • Pactiv General Employee Benefit Trust's largest Q2 2022 buy was Vanguard Short-Term Corporate Bond ETF: 3,061,422 shares worth $233M.
  • Pactiv General Employee Benefit Trust's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $146M.
  • Pactiv General Employee Benefit Trust's ten largest holdings make up 100% of its $332M portfolio in Q2 2022.
  • Pactiv General Employee Benefit Trust opened 2 new positions and closed 0 in Q2 2022.
  • Pactiv General Employee Benefit Trust's portfolio value rose 32% quarter-over-quarter to $332M.

Based on Pactiv General Employee Benefit Trust's 13F filing for Q2 2022, filed 11 Aug 2022.